Reduced circulating sphingolipids and CERS2 activity are linked to T2D that will wow you

By Liam

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

Reduced circulating sphingolipids and CERS2 activity are linked to T2D
Reduced circulating sphingolipids and CERS2 activity are linked to T2D

Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secretion ex vivo. Overall, reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function.

Functional role of T2D relevant IFGs identified by Vec2image
Functional role of T2D relevant IFGs identified by Vec2image

Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secre-tion ex vivo. Overall, reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function.

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

Schematic diagram of the mechanisms of oral anti CD3 plus GC
Schematic diagram of the mechanisms of oral anti CD3 plus GC

Reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function. Gestational diabetes mellitus (GDM), a transient form of diabetes that resolves postpartum, is a major risk factor for type 2 diabetes ( T2D ) in women.

Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion Authors: Khan, Saifur R;Gunderson, Erica P;Wheeler, Michael B; et al.

Beta cell functional and gene regulatory changes in T2D a b Bar plots
Beta cell functional and gene regulatory changes in T2D a b Bar plots

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion

Researchers examined whole-body ceramide synthase 2 ( Cers2 ) knockout and rs267738 knock-in mice. Both models exhibited glucose intolerance and impaired insulin secretion in vivo. Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secretion ex vivo.

Frontiers
Frontiers

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

To explore the role of the CERS2 gene, specifically the rs267738 allele, in glucose regulation and beta-cell function. To establish reduced sphingolipids as a potential biomarker for T2D risk after GDM.

Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion by Cyrus Huneycutt | Feb 12, 2025 | 0 comments

Exosomes from adipocytes of patients with T2D induce morphological
Exosomes from adipocytes of patients with T2D induce morphological

PDF The progression from gestational diabetes to type 2

More information: Saifur R. Khan et al, Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion, Science Advances (2025).

Present immune cells in human pancreatic tissue with T1D T2D and T3cD
Present immune cells in human pancreatic tissue with T1D T2D and T3cD
SIX2 expression is reduced in β cells from T2D donors A Gene
SIX2 expression is reduced in β cells from T2D donors A Gene
Islet QTLs that co localize with T2D signals target distinct pathways
Islet QTLs that co localize with T2D signals target distinct pathways
Skeletal muscle O2 consumption measured in human skeletal myotubes
Skeletal muscle O2 consumption measured in human skeletal myotubes
Islet cell derived EVs promote the development of T1D T2D and diabetic
Islet cell derived EVs promote the development of T1D T2D and diabetic
Cellular senescence in type 2 diabetes T2D Accelerated cellular
Cellular senescence in type 2 diabetes T2D Accelerated cellular

Defects in sphingolipid metabolism were further implicated by integrating metabolomics and genome-wide association data, which identified two significantly enriched T2D - linked genes, CERS2 and CERS4. Follow-up experiments in mice and cells demonstrated that inhibiting sphingolipid metabolism impaired pancreatic β cell function.